Source: Annual Congress 2004 - Method aspects and risk environments of respiratory diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. P. Zock, C. Luczynska, D. Jarvis, on Behalf of ECRHS II (Barcelona, Spain; London, United Kingdom). House dust mites in ECRHS II: determinants of allergen levels. Eur Respir J 2004; 24: Suppl. 48, 1747

Member's Comments

No comment yet.

Related content which might interest you: House dust mites in ECRHS II: methodology and distribution Source: Eur Respir J 2004; 24: Suppl. 48, 268s Year: 2004 House dust mite allergens may induce ASM remodeling/hyperplasia by reducing C/EBPα levels Source: Annual Congress 2007 - New mechanisms in the pathogenesis of asthma and allergy Year: 2007 Lifestyle and indoor air pollution: allergens Source: ISSN=1025-448x, ISBN=1-904097-24-3, page=133 Year: 2002 Mite and cockroach allergen levels in the dust of dwellings of asthmatics and controls in the reunion island Source: Eur Respir J 2003; 22: Suppl. 45, 302s Year: 2003 Association between house dust mites (HDM) level in homes of atopic children and interleukine-4 and IgE in expired air condensate(EAC) Source: Eur Respir J 2002; 20: Suppl. 38, 536s Year: 2002 Natural house dust mites (HDM) exposures in children with allergic airway diseases in Khabarovsk and Vladivistok and rates of HDM sensitization Source: International Congress 2014 – Environment and mechanisms Year: 2014 High altitude and asthma: beyond house dust mites Source: Eur Respir J 2012; 40: 1320-1321 Year: 2012 Association between dust mite sensitisation and asthma severity Source: Annual Congress 2010 - Clinical aspects of asthma and allergic respiratory diseases Year: 2010 House dust mite allergen exposure is associated with sensitisation and asthma in New Zealand infants Source: Eur Respir J 2002; 20: Suppl. 38, 117s Year: 2002 The effect of anti-mite mattress covers on mite allergen levels in the PIAMA (prevention and incidence of asthma and mite allergy) study Source: Eur Respir J 2001; 18: Suppl. 33, 321s Year: 2001 House dust mite (HDM) avoidance and treatment of severe childhood asthma Source: Eur Respir J 2003; 22: Suppl. 45, 314s Year: 2003 House dust mite allergen (Der p1 and Blo t5) levels in asthmatics’ home in HongKong Source: Eur Respir J 2003; 22: Suppl. 45, 481s Year: 2003 House dust mite levels in homes of Danish school children: The DAMIB study Source: Eur Respir J 2003; 22: Suppl. 45, 570s Year: 2003 Collaborative treatment with variety of dust mites allergic in standardized dermatophagoides pteronyssinus allergen immunotherapy Source: International Congress 2016 – Clinical studies in asthma and immunology Year: 2016 OPURIT: Omalizumab-protected ultra rush specific immunotherapy in severe asthmatic patients with house dust mite allergy Source: Annual Congress 2011 - Allergen immunotherapy and anti-immunoglobulin E Year: 2011 Sublingual tablets of house dust mite allergen extracts: Results of a phase I study in adults with mite-associated allergic asthma Source: Annual Congress 2013 –Studies of asthma in man Year: 2013 Late Breaking Abstract - Budget impact of introducing 12SQ HDM SLIT-tablet for house dust mite allergic asthma in Spain Source: International Congress 2019 – How to guide patients to reach a balance between costs and personal needs: quality indicators of effectiveness Year: 2019 Prevention of paediatric asthma and allergy by reduction of house dust mite content Source: Eur Respir J 2001; 18: Suppl. 33, 287s Year: 2001 Respiratory symptoms in relation to indoor exposure to mite and cat allergens and endotoxins Source: Eur Respir J 2001; 18: 555-563 Year: 2001 IgE cross-reactivity between house dust mite and shrimp Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology Year: 2016